Dosage unit for cardioprotection
A method for secondary cardiovascular prevention in a patient includes formulating a single dosage unit containing a beta-adrenergic blocking agent and a cholesterol-lowering agent that is a statin where the single dosage unit contains a quantity of medications sufficient for secondary prevention of...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A method for secondary cardiovascular prevention in a patient includes formulating a single dosage unit containing a beta-adrenergic blocking agent and a cholesterol-lowering agent that is a statin where the single dosage unit contains a quantity of medications sufficient for secondary prevention of a heart attack in the patient, and administering the single dosage unit to the patient for secondary prevention of a heart attack. The method further includes the secondary prevention of a heart attack in a non-hypertensive patient. |
---|